Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Does perioperative prostaglandin E1 affect survival of patients with esophageal cancer?

Farrokhnia F, Makarem J, Mahmoodzadeh H, Andalib N.

World J Gastrointest Surg. 2012 Dec 27;4(12):284-8. doi: 10.4240/wjgs.v4.i12.284.

2.

The effects of prostaglandin E1 on interleukin-6, pulmonary function and postoperative recovery in oesophagectomised patients.

Farrokhnia E, Makarem J, Khan ZH, Mohagheghi M, Maghsoudlou M, Abdollahi A.

Anaesth Intensive Care. 2009 Nov;37(6):937-43.

3.

Effect of prostaglandin E1 on inflammatory responses and gas exchange in patients undergoing surgery for oesophageal cancer.

Nakazawa K, Narumi Y, Ishikawa S, Yokoyama K, Nishikage T, Nagai K, Kawano T, Makita K.

Br J Anaesth. 2004 Aug;93(2):199-203. Epub 2004 May 28.

4.

[A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis].

YANG H, FU JH, LIU MZ, FANG WT, WANG JM, CHEN YP, CHEN ZJ, XIANG JQ, YANG HJ, MAO WM, ZHENG X, ZHU CC, KONG M, HAN YT, LI T.

Zhonghua Yi Xue Za Zhi. 2012 Apr 17;92(15):1028-32. Chinese.

PMID:
22781642
5.

[The effect of low-dose prostaglandin E1 on intra- and post-operative liver function].

Hayashida M, Hanaoka K, Shimada Y, Namiki A, Amaha K.

Masui. 1997 May;46(5):618-27. Japanese.

PMID:
9185458
6.

Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial.

Klein AS, Cofer JB, Pruett TL, Thuluvath PJ, McGory R, Uber L, Stevenson WC, Baliga P, Burdick JF.

Gastroenterology. 1996 Sep;111(3):710-5.

PMID:
8780576
7.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
8.

[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].

Zhang HL, Liu RL, Shi YT, Wang ZC, Wang BH, Li YJ, Zhou LY, Ping YM.

Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):541-5. Chinese.

PMID:
19950705
10.

[Perioperative treatment after esophagogastric surgery].

Nagy K, Murányi M, Nádas G, Tapolcsányi E, Vimláti L.

Magy Seb. 2001 Jun;54(3):138-43. Hungarian.

PMID:
11432163
11.

Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration.

Serra W, Musiari L, Ardissino D, Gherli T, Montanari A.

Int J Cardiol. 2011 Jan 7;146(1):e10-5. doi: 10.1016/j.ijcard.2008.12.173. Epub 2009 Jan 28.

PMID:
19176262
12.

Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.

Pacher R, Globits S, Wutte M, Rödler S, Heinz G, Kreiner G, Radosztics S, Berger R, Presch I, Weber H.

Crit Care Med. 1994 Jul;22(7):1084-90.

PMID:
8026195
13.

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.

Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ.

Ann Surg. 2007 Dec;246(6):992-1000; discussion 1000-1.

PMID:
18043101
14.

[Beneficial effects of metoprolol on perioperative cardiac function of elderly esophageal cancer patients].

Lai RC, Xu MX, Huang WQ, Wang XD, Zeng WA, Lin WQ.

Ai Zheng. 2006 May;25(5):609-13. Chinese.

PMID:
16687084
15.

Treatment of fulminant hepatic failure with intravenous prostaglandin E1.

Sterling RK, Luketic VA, Sanyal AJ, Shiffman ML.

Liver Transpl Surg. 1998 Sep;4(5):424-31.

16.

[Comparison of the results of lymph node dissection via left versus right thoracotomy].

Mao YS, He J, Dong JS, Cheng GY, Sun KL, Liu XY, Fang DK, Li J, Wang YG.

Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):296-300. doi: 10.3760/cma.j.issn.0253-3766.2012.04.013. Chinese.

PMID:
22781044
17.

Prostaglandin E1 as a hypotensive drug during general anesthesia for total hip replacement.

Yukioka H, Asada K, Fujimori M, Shimazu A.

J Clin Anesth. 1993 Jul-Aug;5(4):310-4.

PMID:
8373610
18.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93.

PMID:
15590179
19.

Comparison of the time to extubation after use of remifentanil or sufentanil in combination with propofol as anesthesia in adults undergoing nonemergency intracranial surgery: a prospective, randomized, double-blind trial.

Djian MC, Blanchet B, Pesce F, Sermet A, Disdet M, Vazquez V, Gury C, Roux FX, Raggueneau JL, Coste J, Joly LM.

Clin Ther. 2006 Apr;28(4):560-8.

PMID:
16750467
20.

A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation.

Henley KS, Lucey MR, Normolle DP, Merion RM, McLaren ID, Crider BA, Mackie DS, Shieck VL, Nostrant TT, Brown KA, et al.

Hepatology. 1995 Feb;21(2):366-72.

Supplemental Content

Support Center